Grace Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $20.4M | $128.6M | $30.3M |
| FY2023 | $11.2M | $79.1M | $27.9M |
| FY2024 | $11.6M | $73.3M | $23.0M |
| FY2025 | $5.4M | $72.0M | $22.1M |
| FY2026 | $2.8M | $66.7M | $17.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $20.4M | $128.6M | $30.3M |
| FY2023 | $11.2M | $79.1M | $27.9M |
| FY2024 | $11.6M | $73.3M | $23.0M |
| FY2025 | $5.4M | $72.0M | $22.1M |
| FY2026 | $2.8M | $66.7M | $17.0M |